Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This study intends to perform high-intensity focused ultrasound combined with REGOTORI in
patients with multiline drug-resistant metastatic colorectal cancer to explore the safety and
efficacy of patients. Patients receive HIFU local treatment combined with REGOTORI treatment,
and receive corresponding clinical data collection at different follow-up points, including
necessary data from various laboratories, CT/MRI, and immune function tests that are exactly
the same as before surgery collection.
Phase:
Phase 1
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University